First line and salvage therapy with total therapy 3-based treatment for multiple myeloma––An extended single center experience
Eli Muchtar(Mayo Clinic), Hila Magen(Sheba Medical Center), Nino Oniashvili(Rafael Advanced Defense Systems (Israel)), Moshe Yeshurun, Pia Raanani(Tel Aviv University), Ofer Shpilberg(Texas Oncology), Ron Ram(Tel Aviv University)
Cited by 12
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2017|736
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727